Multidomain patient-reported outcomes of irritable bowel syndrome: Exploring person-centered perspectives to better understand symptom severity Scores

Jeffrey M. Lackner, James Jaccard, Charles Baum

Research output: Contribution to journalArticle

Abstract

Objectives: Patient-reported outcomes assessing multiple gastrointestinal symptoms are central to characterizing the therapeutic benefit of novel agents for irritable bowel syndrome (IBS). Common approaches that sum or average responses across different illness components must be unidimensional and have small unique variances to avoid aggregation bias and misinterpretation of clinical data. This study sought to evaluate the unidimensionality of the IBS Symptom Severity Scale (IBS-SSS) and to explore person-centered cluster analytic methods for characterizing multivariate-based patient profiles. Methods: Ninety-eight Rome-diagnosed patients with IBS completed the IBS-SSS and a single, global item of symptom severity (UCLA Symptom Severity Scale) at pretreatment baseline of a clinical trial funded by the National Institutes of Health. k-means cluster analyses were performed on participants' symptom severity scores. Results: The IBS-SSS was not unidimensional. Exploratory cluster analyses revealed four common symptom profiles across five items of the IBS-SSS. One cluster of patients (25%) had elevated scores on pain frequency and bowel dissatisfaction, with less elevated but still high scores on life interference and low pain severity ratings. A second cluster (19%) was characterized by intermediate scores on both pain dimensions but more elevated scores on bowel dissatisfaction. A third cluster (18%) had elevated scores across all IBS-SSS subcomponents. The fourth and the most common cluster (37%) had relatively low scores on all dimensions except bowel dissatisfaction and life interference due to IBS symptoms. Conclusions: Patient-reported outcome end points and research on IBS more generally relying on multicomponent assessments of symptom severity should take into account the multidimensional structure of symptoms to avoid aggregation bias and to optimize the sensitivity of detecting treatment effects.

Original languageEnglish (US)
Pages (from-to)97-103
Number of pages7
JournalValue in Health
Volume16
Issue number1
DOIs
StatePublished - Jan 2013

Fingerprint

Irritable Bowel Syndrome
Pain
Cluster Analysis
Patient Reported Outcome Measures
Symptom Assessment
National Institutes of Health (U.S.)
Clinical Trials
Therapeutics

Keywords

  • disease severity
  • global assessment
  • health status indicators
  • outcome research
  • psychometric properties
  • questionnaire development
  • rating scale

ASJC Scopus subject areas

  • Health Policy
  • Public Health, Environmental and Occupational Health

Cite this

Multidomain patient-reported outcomes of irritable bowel syndrome : Exploring person-centered perspectives to better understand symptom severity Scores. / Lackner, Jeffrey M.; Jaccard, James; Baum, Charles.

In: Value in Health, Vol. 16, No. 1, 01.2013, p. 97-103.

Research output: Contribution to journalArticle

@article{e5ed09dd30904629935269c32d27c4c7,
title = "Multidomain patient-reported outcomes of irritable bowel syndrome: Exploring person-centered perspectives to better understand symptom severity Scores",
abstract = "Objectives: Patient-reported outcomes assessing multiple gastrointestinal symptoms are central to characterizing the therapeutic benefit of novel agents for irritable bowel syndrome (IBS). Common approaches that sum or average responses across different illness components must be unidimensional and have small unique variances to avoid aggregation bias and misinterpretation of clinical data. This study sought to evaluate the unidimensionality of the IBS Symptom Severity Scale (IBS-SSS) and to explore person-centered cluster analytic methods for characterizing multivariate-based patient profiles. Methods: Ninety-eight Rome-diagnosed patients with IBS completed the IBS-SSS and a single, global item of symptom severity (UCLA Symptom Severity Scale) at pretreatment baseline of a clinical trial funded by the National Institutes of Health. k-means cluster analyses were performed on participants' symptom severity scores. Results: The IBS-SSS was not unidimensional. Exploratory cluster analyses revealed four common symptom profiles across five items of the IBS-SSS. One cluster of patients (25{\%}) had elevated scores on pain frequency and bowel dissatisfaction, with less elevated but still high scores on life interference and low pain severity ratings. A second cluster (19{\%}) was characterized by intermediate scores on both pain dimensions but more elevated scores on bowel dissatisfaction. A third cluster (18{\%}) had elevated scores across all IBS-SSS subcomponents. The fourth and the most common cluster (37{\%}) had relatively low scores on all dimensions except bowel dissatisfaction and life interference due to IBS symptoms. Conclusions: Patient-reported outcome end points and research on IBS more generally relying on multicomponent assessments of symptom severity should take into account the multidimensional structure of symptoms to avoid aggregation bias and to optimize the sensitivity of detecting treatment effects.",
keywords = "disease severity, global assessment, health status indicators, outcome research, psychometric properties, questionnaire development, rating scale",
author = "Lackner, {Jeffrey M.} and James Jaccard and Charles Baum",
year = "2013",
month = "1",
doi = "10.1016/j.jval.2012.08.2207",
language = "English (US)",
volume = "16",
pages = "97--103",
journal = "Value in Health",
issn = "1098-3015",
publisher = "Elsevier Limited",
number = "1",

}

TY - JOUR

T1 - Multidomain patient-reported outcomes of irritable bowel syndrome

T2 - Exploring person-centered perspectives to better understand symptom severity Scores

AU - Lackner, Jeffrey M.

AU - Jaccard, James

AU - Baum, Charles

PY - 2013/1

Y1 - 2013/1

N2 - Objectives: Patient-reported outcomes assessing multiple gastrointestinal symptoms are central to characterizing the therapeutic benefit of novel agents for irritable bowel syndrome (IBS). Common approaches that sum or average responses across different illness components must be unidimensional and have small unique variances to avoid aggregation bias and misinterpretation of clinical data. This study sought to evaluate the unidimensionality of the IBS Symptom Severity Scale (IBS-SSS) and to explore person-centered cluster analytic methods for characterizing multivariate-based patient profiles. Methods: Ninety-eight Rome-diagnosed patients with IBS completed the IBS-SSS and a single, global item of symptom severity (UCLA Symptom Severity Scale) at pretreatment baseline of a clinical trial funded by the National Institutes of Health. k-means cluster analyses were performed on participants' symptom severity scores. Results: The IBS-SSS was not unidimensional. Exploratory cluster analyses revealed four common symptom profiles across five items of the IBS-SSS. One cluster of patients (25%) had elevated scores on pain frequency and bowel dissatisfaction, with less elevated but still high scores on life interference and low pain severity ratings. A second cluster (19%) was characterized by intermediate scores on both pain dimensions but more elevated scores on bowel dissatisfaction. A third cluster (18%) had elevated scores across all IBS-SSS subcomponents. The fourth and the most common cluster (37%) had relatively low scores on all dimensions except bowel dissatisfaction and life interference due to IBS symptoms. Conclusions: Patient-reported outcome end points and research on IBS more generally relying on multicomponent assessments of symptom severity should take into account the multidimensional structure of symptoms to avoid aggregation bias and to optimize the sensitivity of detecting treatment effects.

AB - Objectives: Patient-reported outcomes assessing multiple gastrointestinal symptoms are central to characterizing the therapeutic benefit of novel agents for irritable bowel syndrome (IBS). Common approaches that sum or average responses across different illness components must be unidimensional and have small unique variances to avoid aggregation bias and misinterpretation of clinical data. This study sought to evaluate the unidimensionality of the IBS Symptom Severity Scale (IBS-SSS) and to explore person-centered cluster analytic methods for characterizing multivariate-based patient profiles. Methods: Ninety-eight Rome-diagnosed patients with IBS completed the IBS-SSS and a single, global item of symptom severity (UCLA Symptom Severity Scale) at pretreatment baseline of a clinical trial funded by the National Institutes of Health. k-means cluster analyses were performed on participants' symptom severity scores. Results: The IBS-SSS was not unidimensional. Exploratory cluster analyses revealed four common symptom profiles across five items of the IBS-SSS. One cluster of patients (25%) had elevated scores on pain frequency and bowel dissatisfaction, with less elevated but still high scores on life interference and low pain severity ratings. A second cluster (19%) was characterized by intermediate scores on both pain dimensions but more elevated scores on bowel dissatisfaction. A third cluster (18%) had elevated scores across all IBS-SSS subcomponents. The fourth and the most common cluster (37%) had relatively low scores on all dimensions except bowel dissatisfaction and life interference due to IBS symptoms. Conclusions: Patient-reported outcome end points and research on IBS more generally relying on multicomponent assessments of symptom severity should take into account the multidimensional structure of symptoms to avoid aggregation bias and to optimize the sensitivity of detecting treatment effects.

KW - disease severity

KW - global assessment

KW - health status indicators

KW - outcome research

KW - psychometric properties

KW - questionnaire development

KW - rating scale

UR - http://www.scopus.com/inward/record.url?scp=84872722307&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872722307&partnerID=8YFLogxK

U2 - 10.1016/j.jval.2012.08.2207

DO - 10.1016/j.jval.2012.08.2207

M3 - Article

VL - 16

SP - 97

EP - 103

JO - Value in Health

JF - Value in Health

SN - 1098-3015

IS - 1

ER -